ETON
HEALTHCAREEton Pharmaceuticals Inc
$30.15-0.23 (-0.76%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ETON Today?
No stock-specific AI insight has been generated for ETON yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$13.09$32.31
$30.15
Fundamentals
Market Cap$825M
P/E Ratio—
EPS$-0.17
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume493K
Avg Volume (10D)—
Shares Outstanding27.4M
ETON News
20 articles- Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 7, 2026
- Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 6, 2026
- Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026Yahoo Finance·May 4, 2026
- Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains?Yahoo Finance·May 4, 2026
- How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON)Yahoo Finance·May 3, 2026
- Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy DistributionYahoo Finance·May 1, 2026
- Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700Yahoo Finance·Apr 27, 2026
- Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFOYahoo Finance·Apr 24, 2026
- How The Hemangeol Deal Is Reframing The Eton Pharmaceuticals (ETON) Investment StoryYahoo Finance·Apr 19, 2026
- Eton Pharmaceuticals Announces CFO Succession PlanYahoo Finance·Apr 16, 2026
- April 2026's Top Growth Companies With Strong Insider OwnershipYahoo Finance·Apr 13, 2026
- How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation TargetsYahoo Finance·Apr 5, 2026
- Tarsus Pharmaceuticals Stock Earns Upgrade To RS RatingYahoo Finance·Mar 26, 2026
- Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?Yahoo Finance·Mar 24, 2026
- Recent Price Trend in Eton Pharmaceuticals (ETON) is Your Friend, Here's WhyYahoo Finance·Mar 23, 2026
- Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?Yahoo Finance·Mar 20, 2026
- Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...Yahoo Finance·Mar 20, 2026
- Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 20, 2026
- Eton Pharmaceuticals Q4 Earnings Call HighlightsMarketbeat·Mar 19, 2026
- Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag EstimatesYahoo Finance·Mar 19, 2026
All 20 articles loaded
Price Data
Open$24.62
Previous Close$30.38
Day High$29.80
Day Low$24.62
52 Week High$32.31
52 Week Low$13.09
52-Week Range
$13.09$32.31
$30.15
Fundamentals
Market Cap$825M
P/E Ratio—
EPS$-0.17
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume493K
Avg Volume (10D)—
Shares Outstanding27.4M
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—